发明名称 |
Therapeutic use of mucin glycans |
摘要 |
A therapeutic formulation containing mucin glycans derived from one or a number of nutritionally appropriate sources is described. |
申请公布号 |
US8795746(B2) |
申请公布日期 |
2014.08.05 |
申请号 |
US201213397556 |
申请日期 |
2012.02.15 |
申请人 |
The Board of Trustees of the Leland Stanford Junior University |
发明人 |
Sonnenburg Justin L. |
分类号 |
A23C9/20;A23L1/30;C13K13/00 |
主分类号 |
A23C9/20 |
代理机构 |
Bozicevic, Field & Francis LLP |
代理人 |
Bozicevic, Field & Francis LLP ;Sherwood Pamela J. |
主权项 |
1. An infant formula supplement comprising:
(i) mammalian mucin glycans released and isolated from the protein component of mammalian mucins purified to comprise less than 10% by weight protein, which mucin glycans are a heterogenous mixture of linear and branched oligosaccharides from about 2 to about 10 saccharide subunits in length, that selectively stimulate growth of desirable gut microorganisms comprising Bacteroides species, wherein the mucin glycans upregulate a set of polysaccharide utilization loci (PULs) in said Bacteroides species similar to those PULs upregulated in response to human milk oligosaccharides (HMO); and optionally (ii) at least one human milk oligosaccharide (HMO). |
地址 |
Palo Alto CA US |